Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

CONTEXT: We examined if empagliflozin was associated with modulation of cardiac autonomic tone among subjects with type 2 diabetes and stable coronary artery disease (CAD) relative to placebo. METHODS: Using ambulatory 24-h Holter electrocardiographic data prospectively collected from a randomized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Vinay, Verma, Subodh, Connelly, Kim A., Yan, Andrew T., Sikand, Aditya, Garg, Ankit, Dorian, Paul, Zuo, Fei, Leiter, Lawrence A., Zinman, Bernard, Jüni, Peter, Verma, Atul, Teoh, Hwee, Quan, Adrian, Mazer, C. David, Ha, Andrew C.T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424781/
https://www.ncbi.nlm.nih.gov/pubmed/32812924
http://dx.doi.org/10.1016/j.metop.2020.100039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424781/
https://www.ncbi.nlm.nih.gov/pubmed/32812924
http://dx.doi.org/10.1016/j.metop.2020.100039

Ejemplares similares